30
Participants
Start Date
September 6, 2026
Primary Completion Date
September 6, 2028
Study Completion Date
September 6, 2028
Ketone-IQ
This is a crossover study where participants will ingest either Ketone-IQ for 2 nights, or placebo for 2 nights before sleep. This is the Ketone-IQ (1,3 Butanediol) intervention.
Placebo
This is a crossover study where participants will ingest either Ketone-IQ for 2 nights, or placebo for 2 nights before sleep. This is the Placebo intervention.
Johns Hopkins Bayview Medical Center, Baltimore
HVMN Inc
INDUSTRY
KETONE-IQ
UNKNOWN
Johns Hopkins University
OTHER